Skip to Main Content

Paper Details

Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86.
Cell Host Microbe
0
2024
BA.2, BA.2 sequences, BA.2.86 epitopes., BA.2.86 mutations, CD8, HLA-restricting alleles, SARS, SARS-, SARS-2-specific T cells, SARS-CoV, SARS-CoV-2, SARS-CoV-2 CD4, T cell, T cell epitopes, epitopes
Author NameAffiliation
Alessandro SetteCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), University of California, San Diego (university of california san diego)
Alessandro SetteCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), University of California, San Diego (university of california san diego)
John SidneyCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI)
  • 1 - 3

Datasets

Release 1.2